Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,592,459
+$139,588 QoQ
Shares Held
36,350
+13.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#599
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROWLANDMILLER & PARTNERS.ADV holds $61,867,127 across 7 Drug Manufacturers - General names. GILD ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,075 | $18,081,408 | |
| 2 | JNJ |
Johnson & Johnson
|
64,152 | $16,292,683 | |
| 3 | ABBV |
AbbVie Inc.
|
43,246 | $10,882,423 | |
| 4 | AMGN |
Amgen Inc
|
14,748 | $5,340,545 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,007 | $4,755,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
36,350 | $4,592,459 | |
| 7 | PFE |
Pfizer Inc
|
79,826 | $1,922,210 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,592,459 | 36,350 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,452,871 | 31,950 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $4,034,709 | 32,872 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,648,681 | 32,871 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $3,751,951 | 33,841 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $3,807,010 | 33,976 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,138,270 | 33,975 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,844,942 | 33,933 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,369,926 | 34,542 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,969,994 | 40,546 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $3,303,911 | 40,784 | Shares | Sole | 2024-01-03 | |
| 2023-09-30 | $3,081,083 | 41,114 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,204,031 | 41,573 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,463,914 | 41,749 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $3,595,827 | 41,885 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $2,893,877 | 46,910 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $2,850,924 | 46,124 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,667,343 | 44,867 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,028,200 | 41,705 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,836,566 | 26,293 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,448,937 | 35,564 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,267,543 | 35,085 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,740,167 | 29,869 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,624,867 | 25,714 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,022,983 | 26,293 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,922,378 | 25,714 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||